BBusiness Read More Eli Lilly will file for approval of retatrutide obesity drug in 2027July 23, 2026 The Eli Lilly logo appears on the company’s office in San Diego, California, Nov. 21, 2025. Mike Blake…
BBusiness Read More Novo Nordisk sues Eli Lilly over GLP-1 adsJuly 21, 2026 Photo illustration of a group of weight loss medications on a white background. Ucg | Universal Images Group…
HHealthcare Read More What to know about testosterone replacement therapyJuly 20, 2026 US Secretary of Defense Pete Hegseth speaks during a press briefing at the Pentagon in Washington, DC, on…
HHealthcare Read More Market for psychedelic drugs to treat mental health gets a buy signalJuly 20, 2026 Psilocybin mushrooms stand ready for harvest in a humidified “fruiting chamber.” John Moore | Getty Images Thursday’s announcement…
MMedication Read More Ozempic for cats? GLP-1 weight-loss drugs are coming for your fat petJuly 18, 2026 A beautiful, but over weight Maine Coon Cat gets measured around the belly by a vet. Ryersonclark |…
HHealthcare Read More UnitedHealth Group (UNH) earnings Q2 2026July 16, 2026 UnitedHealth Group on Thursday posted second-quarter earnings that blew past estimates and raised its full-year profit outlook, as…
HHealthcare Read More Eli Lilly to buy psychedelics maker AtaiBeckley for $2.8 billionJuly 16, 2026 The Eli Lilly logo appears on the company’s office in San Diego, California, Nov. 21, 2025. Mike Blake…
HHealthcare Read More Johnson & Johnson (JNJ) Q2 earningsJuly 15, 2026 Johnson & Johnson beat Wall Street estimates for second-quarter sales and profit on Wednesday, as strong growth from…
HHealthcare Read More Johnson & Johnson has a chance to show it’s more than just a rotation winnerJuly 14, 2026 Johnson & Johnson shares have showed signs of life ahead of earnings. For the stock to keep running,…
HHealthcare Read More GLP-1 implant from Vivani Medical aims to help patients stay on treatmentJuly 11, 2026 Michael Siluk | UCG | Universal Images Group | Getty Images Losing weight with GLP-1 drugs is only…
BBusiness Read More AstraZeneca’s trial flop raises bigger questions around its pipelineJuly 11, 2026 AstraZeneca‘s failed late-stage trial for Wainua was never expected to have a major financial impact on the company.…
HHealthcare Read More AstraZeneca stock dives 9% after heart drug trial misses targetJuly 9, 2026 Shares of AstraZeneca fell as much as 9% after a late-stage clinical trial for a heart disease drug…